summary
Introduced
02/12/2025
02/12/2025
In Committee
02/12/2025
02/12/2025
Crossed Over
Passed
Dead
Introduced Session
119th Congress
Bill Summary
A BILL To prohibit certain uses of xylazine, and for other purposes.
AI Summary
This bill addresses the regulation of xylazine, a veterinary sedative that has increasingly been used illicitly in drug mixtures. The bill first defines xylazine comprehensively, including its salts and isomers, and adds it to Schedule III of the Controlled Substances Act, which means it will be subject to federal drug control regulations. The legislation establishes specific rules for xylazine's use, primarily limiting its possession to veterinarians, registered pharmacies, and specific contexts like animal control and wildlife programs. The bill provides a transition period for manufacturers and practitioners, giving them time to adapt to the new regulations, and requires the Drug Enforcement Administration and Food and Drug Administration to expedite the necessary administrative processes. Additionally, the bill mandates two reports to Congress - an initial report within 18 months examining xylazine's prevalence, diversion, origin, and potential abuse risks, and a follow-up report after four years updating Congress on trafficking and misuse trends. The United States Sentencing Commission is also directed to review and potentially amend sentencing guidelines to provide appropriate penalties for offenses involving xylazine, taking into account its use alongside other controlled substances.
Committee Categories
Business and Industry
Sponsors (87)
Jimmy Panetta (D)*,
Jake Auchincloss (D),
Don Bacon (R),
Jim Baird (R),
Troy Balderson (R),
Nanette Barragán (D),
Cliff Bentz (R),
Stephanie Bice (R),
Gus Bilirakis (R),
Nikki Budzinski (D),
Tim Burchett (R),
Ken Calvert (R),
Mike Carey (R),
Buddy Carter (R),
Sheila Cherfilus-McCormick (D),
Juan Ciscomani (R),
Yvette Clarke (D),
Steve Cohen (D),
Mike Collins (R),
Lou Correa (D),
Jim Costa (D),
Angie Craig (D),
Dan Crenshaw (R),
Sharice Davids (D),
Don Davis (D),
Madeleine Dean (D),
Suzan DelBene (D),
Chris Deluzio (D),
Brad Finstad (R),
Michelle Fischbach (R),
Scott Fitzgerald (R),
Brian Fitzpatrick (R),
Vince Fong (R),
Adam Gray (D),
Glenn Grothman (R),
Josh Harder (D),
Mike Haridopolos (R),
Andy Harris (R),
Diana Harshbarger (R),
Pablo Jose Hernandez (D),
Ronny Jackson (R),
Dusty Johnson (R),
Robin Kelly (D),
Timothy Kennedy (D),
Young Kim (R),
Brad Knott (R),
Laurel Lee (R),
Julia Letlow (R),
Frank Lucas (R),
Seth Magaziner (D),
Tracey Mann (R),
Sarah McBride (D),
Kristen McDonald Rivet (D),
Addison McDowell (R),
Mariannette Miller-Meeks (R),
Dave Min (D),
Troy Nehls (R),
Donald Norcross (D),
Zach Nunn (R),
Jay Obernolte (R),
Chris Pappas (D),
Brittany Pettersen (D),
August Pfluger (R),
Deborah Ross (D),
David Rouzer (R),
Michael Rulli (R),
Andrea Salinas (D),
Hillary Scholten (D),
Keith Self (R),
Terri Sewell (D),
Mike Simpson (R),
Chris Smith (R),
Eric Sorensen (D),
Darren Soto (D),
Bryan Steil (R),
Tom Suozzi (D),
Claudia Tenney (R),
Mike Thompson (D),
Jill Tokuda (D),
Jeff Van Drew (R),
Beth Van Duyne (R),
Derrick Van Orden (R),
Eugene Vindman (D),
Randy Weber (R),
Daniel Webster (R),
Rob Wittman (R),
Rudy Yakym (R),
Last Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 02/12/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/119th-congress/house-bill/1266/all-info |
| BillText | https://www.congress.gov/119/bills/hr1266/BILLS-119hr1266ih.pdf |
Loading...